EMEA-000014-PIP01-07-M06

Invented name	Invega
Active substance	paliperidone paliperidone palmitate
Therapeutic area	Psychiatry
Decision number	P/154/2011
PIP number	EMEA-000014-PIP01-07-M06
Pharmaceutical form(s)	Prolonged-release tablet Suspension for injection
Condition(s) / indication(s)	Schizoaffective disorder Schizophrenia
Route(s) of administration	Oral use Intramuscular use
Contact for public enquiries	Janssen-Cilag International NV bbyl@gcpbe.jnj.com Belgium Phone: +32 14607172 Fax: +32 473839426
Decision type	PM: decision on the application for modification of an agreed PIP
Compliance procedure number	EMEA-C-000014-PIP01-07-M06
Compliance opinion date	14/02/2013
Compliance outcome	positive

Add your rating

★ ★ ★ ★ ★